中文 | ENG

第58卷 第1期 2025-1
Ensuring authorship qualification in clinical research articles: A focus on surgical therapy studies

.........................

第58卷 第1期 2025-1
Estimated risk for transfusion of monkeypox contaminated perioperative blood transfusion: A call to action for stronger regulations and testing protocols

.........................

第58卷 第1期 2025-1
Insights into traumatic and crisis surgery: Implications of data analysis in conflict zones

.........................

第58卷 第1期 2025-1
Tongue peeling as an adverse reaction with use of micronized purified flavonoid: A case report

.........................

第58卷 第1期 2025-1
Pilonidal sinus of scrotum: A rare clinical entity

.........................

第58卷 第1期 2025-1
Incidental autopsy finding of retiform hemangioendothelioma of the spleen

.........................

第58卷 第1期 2025-1
Retroperitoneal laparoscopy for hydronephrosis due to multiple fibroepithelial polyps: A case series

.........................

第58卷 第1期 2025-1
Case reports of type 1 cystic biliary atresia—A rare variant of biliary atresia alongwith reviewof literature

.........................

第58卷 第1期 2025-1
The predictors of intraoperative surgical expenses in liver resection for hepatocellular carcinoma

.........................

第58卷 第1期 2025-1
Intracorporeal anastomosis versus extracorporeal anastomosis following laparoscopic right hemicolectomy: Surgical outcomes of a single-center observational study

.........................

第58卷 第1期 2025-1
Quality of life and spiritual health in motorcycle accident survivors: An analysis using the SF-36 Questionnaire and Spiritual Scale

.........................

第58卷 第1期 2025-1
Plastin 3 expression in circulating tumor cells as a predictor of cancer status in patients with prostate cancer

.........................

第57卷 第6期 2024-11
Emerging robot-guided techniques in endodontic microsurgery

.........................

第57卷 第6期 2024-11
Management of subcapsular hematoma after living donor liver transplant

.........................

第57卷 第6期 2024-11
Urethral pseudodiverticulum with left-sided nonfunctioning kidney: Case report

.........................

第57卷 第6期 2024-11
Strategy to minimize surgical defect of dermatofi brosarcoma protuberans

.........................

第57卷 第6期 2024-11
Rapunzel syndrome—An uncommon disease with varied common presentations

.........................

第57卷 第6期 2024-11
Minimally invasive approaches to management of acute necrotizing pancreatitis

.........................

第57卷 第6期 2024-11
Innovative surgical technique: Addressing ethical concerns

.........................

第57卷 第6期 2024-11
Emergency surgery and HIV screening, clinical or universal scenarios?

.........................
登入帳號才能閱讀全文
 
篇名 Management of Complicated Recurrent or Residual Hepatolithiasis
作者 Kuo-Shyang Jeng
卷期/出版年月 43卷5期 (2010/10)
頁次 224-228
摘要 As the patterns of gallstone disease have changed, those with recurrent or residual hepatolithiasis (the so-called complicated hepatoliththiasis) are becoming more and more problematic. How to treat them properly is a new challenge. Contrast cholangiography as well as computed tomography or magnetic resonance cholangiography is necessary to delineate the location of stones, duct strictures, and possible coexisting malignancy preceding surgical or other biliary interventions. Resection of the involved segment or lobe of the liver is a safe and effective treatment for localized hepatolithiasis. Cholangioscopic lithotomy, either intraoperative, postoperative, or a percutaneous minimally invasive procedure without reoperation is important in stone eradication. Chemical biliary duct embolization to prevent stone recurrence has recently been reported. The antagonist of the epidermal growth factor receptor might suppress proliferative cholangitis in animal studies. To obtain a good long term outcome, it is important to keep in mind the possibility of coexisting intrahepatic cholangiocarcinoma, either before, during, or after treatment of complex hepatolithiasis. For complicated hepatolithiasis, a systematic approach with multimodal treatment by a cooperative team is recommended.
關鍵詞 recurrent or residual hepatolithiasis, cholangiocarcinoma
分類 Mini Review

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@surgery.org.tw